Home
Neurotech International Ltd
NTI initiates First Clinical Site for Phase 3 ASD Trial
Business
Mar 17 2026
3 min read

NTI initiates First Clinical Site for Phase 3 ASD Trial

news images

Neurotech International Ltd has released a press release.

View Attachment